Drug Puts A $750,000 'Price Tag On Life'
August 01, 2017 ・0 comments ・Topic： News Headlines trending news headlines
Drug Puts A $750,000 'Price Tag On Life'
The high cost of Spinraza, a new and promising treatment for spinal muscular atrophy, highlights how the cost-benefit analysis insurers use to make drug coverage decisions plays out in human terms.
Read more
Post a Comment
WE LOVE TO HEAR YOUR COMMENTS
If you can't commemt, try using Chrome instead.